Literature DB >> 20117349

Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures.

Kirk M Doing1, Marilyn S Hintz, Calvin Keefe, Sarah Horne, Shelby LeVasseur, Martha L Kulikowski.   

Abstract

Enzyme immunoassays are currently the most common tests used in the clinical laboratory for the detection of Clostridium difficile toxins; however, significant problems with their performance have recently been described. We prospectively reevaluated the Meridian Premier C. difficile toxin A/B assay with direct comparison to a 2-step algorithm that screened for C. difficile common antigen and compared cytotoxin and real-time polymerase chain reaction (PCR) as confirmatory procedures. The Premier assay lacked sufficient sensitivity, missing 25% of true-positive samples. PCR was the most sensitive method and the only procedure that allowed same day testing and reporting. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117349     DOI: 10.1016/j.diagmicrobio.2009.09.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

1.  Laboratory diagnosis of Clostridium difficile infection.

Authors:  S D Goldenberg; P R Cliff; G L French
Journal:  J Clin Microbiol       Date:  2010-08       Impact factor: 5.948

Review 2.  Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?

Authors:  Fred C Tenover; Ellen Jo Baron; Lance R Peterson; David H Persing
Journal:  J Mol Diagn       Date:  2011-08-18       Impact factor: 5.568

3.  Combination of culture, antigen and toxin detection, and cytotoxin neutralization assay for optimal Clostridium difficile diagnostic testing.

Authors:  Michelle J Alfa; Shadi Sepehri
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

4.  Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.

Authors:  Bobby L Boyanton; Preethi Sural; Caroline R Loomis; Christine Pesta; Laura Gonzalez-Krellwitz; Barbara Robinson-Dunn; Paul Riska
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

Review 5.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections.

Authors:  Karissa Culbreath; Edward Ager; Ronald J Nemeyer; Alan Kerr; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

7.  Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.

Authors:  Fred C Tenover; Susan Novak-Weekley; Christopher W Woods; Lance R Peterson; Thomas Davis; Paul Schreckenberger; Ferric C Fang; Andre Dascal; Dale N Gerding; Jim H Nomura; Richard V Goering; Thomas Akerlund; Alice S Weissfeld; Ellen Jo Baron; Edith Wong; Elizabeth M Marlowe; Joseph Whitmore; David H Persing
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

8.  Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.

Authors:  Jodie A Barkin; Neilanjan Nandi; Nancimae Miller; Alexandra Grace; Jamie S Barkin; Daniel A Sussman
Journal:  Dig Dis Sci       Date:  2012-05-11       Impact factor: 3.199

9.  Extraction and sensitive detection of toxins A and B from the human pathogen Clostridium difficile in 40 seconds using microwave-accelerated metal-enhanced fluorescence.

Authors:  Lovleen Tina Joshi; Buddha L Mali; Chris D Geddes; Les Baillie
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

10.  Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).

Authors:  E Bouza; J M Aguado; L Alcalá; B Almirante; P Alonso-Fernández; M Borges; J Cobo; J Guardiola; J P Horcajada; E Maseda; J Mensa; N Merchante; P Muñoz; J L Pérez Sáenz; M Pujol; E Reigadas; M Salavert; J Barberán
Journal:  Rev Esp Quimioter       Date:  2020-02-20       Impact factor: 1.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.